Labs / Assays & in vitro testing
Kyinno Bio
Beijing, China · kyinno.com
Kyinno Bio is a preclinical contract research organization serving biotechnology and pharmaceutical clients. It provides in vitro and in vivo pharmacology, cell line engineering, antibody discovery, and target identification services from Beijing, China, with a business hub in Boston, USA.
They take quote requests by email.
What they offer
In vitro services
Performs cell-based and biochemical in vitro studies for oncology and immunology research, including functional assays and target engagement studies.
Cell proliferation assay
Measures compound effects on cell growth and viability using readouts such as CellTiter-Glo, CellCyte, BrdU, and flow cytometry.
MegaScreen cell panel screening
Screens compounds across a panel of human cancer cell lines for hit identification, lead optimization, and biomarker development.
In vivo services
Offers in vivo pharmacology models for preclinical evaluation, including xenograft, humanized mouse, syngeneic, orthotopic, subcutaneous, and metastasis models.
Antibody discovery services
Provides antibody discovery workflows including common light chain, nanobody discovery, AI-based antibody engineering, and off-target screening.
Multispecific antibody development platform
Develops bispecific, trispecific, and nanobody-based antibodies using proprietary gene-edited mouse platforms.
AI-based antibody development platform
Uses an AI platform to predict antigen-antibody structures and binding affinities, screen antibody sequence libraries, and support affinity maturation.
Genetically engineered cell lines
Develops and supplies engineered cell lines for disease, therapy, and biological process studies.
Drug combination services
Evaluates in vitro and in vivo combination studies for drug development programs.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Cell therapy
- Species and models
- human cancer cell lines, PBMC humanized mouse, syngeneic mouse, orthotopic model, subcutaneous model, metastasis model, Ba/F3 xenograft model, gene-editing xenograft model, luciferase tumor model
- Assays and studies
- cell proliferation, cell viability, cell panel screening, immuno-oncology assay, ADCC, ADCP, ELISA, FACS binding assay, internalization assay, 3D organoid culture, immune cell assay
- Instruments and platforms
- CellTiter-Glo, CellCyte, BrdU, flow cytometry, Digital PCR, mass spectrometry
- Scale and capacity
- 3000+ engineered cell lines, 5000-antibody specificity screening MPSA-AB5000 panel, over 700 sequenced and certified human cancer cell lines, 100+ validated assay platforms, 6000+ cell lines available, 5-floor, 5000m² laboratory, 130 professionals, over 1,000 partners
- Therapeutic areas
- oncology, immunology, cancer drug discovery, cancer drug development
- Turnaround
- 2 - 14 day Standard Assay Window
- What to send
- custom assays · custom antibodies · cell lines · in vivo model requests
- Type
- CRO
- Sites
- Beijing, China · Woburn, MA, USA
- Team
- 130 professionals
- Quality
- GLP-Aligned QC · GLP-Aligned Protocols
- Serves
- global
- Address
- 3 Gill Street, suite 100, Woburn, MA, 01801
- Founded
- 2017
Similar labs. Sparx BIO, Evotec, Transcenta Holding, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from kyinno.com. Work here? Claim this listing.